• Second year mitigation vs suppression strategy Covid19

    From legg@21:1/5 to All on Thu Mar 3 15:25:21 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in eaerly 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.

    Comparison charts, as of Mar 01 are available:


    http://ve3ute.ca/query/220301_cases_ppm_report_group.jpg
    http://ve3ute.ca/query/220301_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220301_deaths_ppm_report_group.jpg
    http://ve3ute.ca/query/220301_deaths_daily_ppm_report_group.jpg
    http://ve3ute.ca/query/220301_deaths_daily_ppm_world_map.jpg

    http://ve3ute.ca/query/220301_vaccine_doses_report_group.jpg
    http://ve3ute.ca/query/220301_vaccine_doses_daily_report_group.jpg
    http://ve3ute.ca/query/220301_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_030c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    A possible peaking in covid-omicron detections may be indicated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Feb28:

    US detections are at 237115ppm.(23.7%)
    Detection rate is 198ppm/day and falling.
    Fatalities are 2849ppm at 5.3ppm/day.
    FR is 1.2% from a 235733ppm detection recorded 7 days previously.
    Case FR short term is currently 1.5%.
    US test rate is 3030ppm/day
    6.5% of current tests are positive.
    Vaccinations at 167% at 600ppm/day
    - with 65% fully vaccinated.

    Canada detections at 86251ppm (8.6%) ~ 364 days behind the US.
    Detection rate at 158ppm/day and falling.
    Fatalities are 960ppm at 1.9ppm/day. ~ 435 days behind the US.
    FR is 1.1% from a 85075ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9%.
    Canada test rate is 1300ppm/day
    12.2% of current tests are positive.
    Vaccinations at 212% at 1700ppm/day
    - with 81% fully vaccinated.

    Italy detections at 211448ppm. (21.1%)
    Detection rate is 697ppm/day and falling.
    Fatalities are 2560ppm at 3.7ppm/day.
    FR is 1.2% from a 206568ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4%.
    Italy test rate is 7080ppm/day.
    9.8% of current tests are positive.
    Vaccinations at 222% at 1900ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 240266ppm (24.0%)
    Detection rate is 257ppm/day and falling.
    Fatalities are 1687ppm at 4.1ppm/day.
    FR is 0.7% from a 238466ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5%.
    Sweden test rate is 1010ppm/day.
    25.0% of tests are positive.
    Vaccinations at 201% at 2500ppm/day
    - with 75% fully vaccinated.

    UK detections at 276437ppm. (27.6%)
    Detection rate is 546ppm/day and falling.
    Fatalities are 2366ppm at 1.8ppm/day.
    FR is 0.9% from a 273491ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    UK test rate is 10930ppm/day.
    5.0% of current tests are positive.
    Vaccinations at 205% at 800ppm/day
    - with 72% fully vaccinated.

    Brazil detections at 134475ppm. (13.4%)
    Detection rate is 373ppm/day and falling.
    Fatalities are 3035ppm at 3.2ppm/day
    FR is 2.3% from a 131875ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Brazil test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 183% at 4400ppm/day
    - with 72% fully vaccinated.

    Peru detections at 105405ppm. (10.5%)
    Detection rate is 87ppm/day and falling.
    Fatalities are 6311ppm at 4.6ppm/day.
    FR is 6.0% from a 104798ppm detection recorded 7 days previously.
    Case FR short term is currently 1.4% .
    Peru test rate is 1590ppm/day.
    5.5% of tests are positive.
    Vaccinations at 183% at 4600ppm/day
    - with 72% fully vaccinated

    Chile detections at 158304ppm (15.8%)
    Detection rate is 1413ppm/day and falling.
    Fatalities are 2197ppm at 6.3ppm/day.
    FR is 1.6% from a 136445ppm detection recorded 14 days previously.
    Case FR short term is currently 0.4% .
    Chile test rate is 4960ppm/day.
    28.5% of current tests are positive.
    Vaccinations at 251% at 4100ppm/day
    - with 89% fully vaccinated.

    Argentina detections at 195089ppm (19.5%)
    Detection rate is 218ppm/day and falling.
    Fatalities are 2765ppm at 2.6ppm/day.
    FR is 1.4% from a 193561ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9% .
    Argentina test rate is 760ppm/day.
    No test positivity rate is practical.
    Vaccinations at 205% at 3700ppm/day
    - with 79% fully vaccinated.

    Mexico detections at 42269ppm (4.2%)
    Detection rate is 101ppm/day and falling.
    Fatalities are 2442ppm at 2.6ppm/day.
    FR is 5.9% from a 41558ppm detection recorded 7 days previously.
    Case FR short term is currently 1.4% .
    Mexico test rate is 80ppm/day.
    No test positivity rate is practical.
    Vaccinations at 139% at 4100ppm/day.
    - with 60% fully vaccinated.

    South Africa detections at 61178ppm (6.1%)
    Detection rate is 35ppm/day and falling.
    Fatalities are 1653ppm at 1.3ppm/day.
    FR is 2.7% from a 60933ppm detection recorded 7 days previously.
    Case FR short term is currently 3.3%.
    SA test rate is 450ppm/day.
    7.8% of current tests are positive.
    Vaccinations at 52% at 1200ppm/day
    - with 29% fully vaccinated.(a rounding error?)

    Czech detections at 333285ppm (33.3%)
    Detection rate is 909ppm/day and falling.
    Fatalities are 3598ppm at 4.9ppm/day.
    FR is 1.1% from a 326920ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3% .
    Czech test rate is 4380ppm/day.
    20.8% of current tests are positive.
    Vaccinations at 162% at 600ppm/day
    - with 64% fully vaccinated.

    India detections at 30805ppm (3.1%)
    Detection rate is 9ppm/day and falling.
    Fatalities at 369ppm at 0.2ppm/day.
    FR is 1.2% from a 30744ppm detection recorded 7 days previously.
    Case FR short term is currently 0.7% .
    India test rate 760ppm/day.
    1.2% of current tests are positive.
    Vaccinations at 129% at 2900ppm/day
    - with 56% fully vaccinated.

    Israel detections at 390242ppm (39.0%)
    Detection rate is 1121ppm/day and falling.
    Fatalities at 1093ppm at 2.8ppm/day.
    FR is 0.3% from a 382398ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 7990ppm/day.
    14.0% of current tests are positive
    Vaccinations at 194% at 200ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Hungary - 10.2ppm/day
    Greenland - 10.1ppm/day
    Georgia - 10.1ppm/day
    Latvia - 9.3ppm/day
    Bulgaria - 9.1ppm/day
    Lithuania - 8.4ppm/day
    Croatia - 7.5ppm/day
    Serbia - 7.3ppm/day
    Macedonia - 7.1ppm/day
    Estonia - 6.8ppm/day
    Denmark - 6.7ppm/day
    Bosnia - 6.5ppm/day
    Chile - 6.3ppm/day
    Greece - 6.3ppm/day
    Armenia - 6.1ppm/day
    Slovenia - 6.1ppm/day
    Romania - 6.1ppm/day
    Ukraine - ~5.9ppm/day
    Poland - 5.7ppm/day
    Slovakia - 5.6ppm
    Trinidad and Tobago - 5.6ppm/day
    USA - 5.3ppm/day
    Russia - 5.2ppm/day


    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Tue Mar 8 09:31:12 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in eaerly 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220301_cases_ppm_report_group.jpg http://ve3ute.ca/query/220301_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220301_deaths_report_group.jpg http://ve3ute.ca/query/220301_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220301_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220301_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220301_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    A possible peaking in covid-omicron detections may be indicated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Mar07:

    US detections are at 238317ppm.(23.8%)
    Detection rate is 127ppm/day and falling.
    Fatalities are 2885ppm at 4.1ppm/day.
    FR is 1.2% from a 237115ppm detection recorded 7 days previously.
    Case FR short term is currently 2.1%.
    US test rate is 2890ppm/day
    4.4% of current tests are positive.
    Vaccinations at 167% at 400ppm/day
    - with 65% fully vaccinated.

    Canada detections at 87851ppm (8.8%) ~ 363 days behind the US.
    Detection rate at 157ppm/day and possibly leveling below 200ppm/day.
    Fatalities are 974ppm at 1.5ppm/day. ~ 441 days behind the US.
    FR is 1.1% from a 86251ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9%.
    Canada test rate is 1220ppm/day
    12.9% of current tests are positive.
    Vaccinations at 214% at 1000ppm/day
    - with 81% fully vaccinated.

    Italy detections at 216156ppm. (21.6%)
    Detection rate is 629ppm/day and falling.
    Fatalities are 2584ppm at 3.0ppm/day.
    FR is 1.2% from a 211448ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4%.
    Italy test rate is 6250ppm/day.
    10.0% of current tests are positive.
    Vaccinations at 223% at 1300ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 241725ppm (24.2%)
    Detection rate is 208ppm/day and falling.
    Fatalities are 1724ppm at 5.2ppm/day.
    FR is 0.7% from a 240266ppm detection recorded 7 days previously.
    Case FR short term is currently 1.7%.
    Sweden test rate is 820ppm/day.
    25.4% of tests are positive.
    Vaccinations at 203% at 2800ppm/day
    - with 75% fully vaccinated.

    UK detections at 282940ppm. (28.3%)
    Detection rate is 757ppm/day and rising.
    Fatalities are 2379ppm at 1.7ppm/day.
    FR is 0.9% from a 276437ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3%.
    UK test rate is 9570ppm/day.
    7.9% of current tests are positive.
    Vaccinations at 205% at 700ppm/day
    - with 72% fully vaccinated.

    Brazil detections at 135882ppm. (13.6%)
    Detection rate is 188ppm/day and falling.
    Fatalities are 3050ppm at 2.0ppm/day
    FR is 2.3% from a 134475ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5% .
    Brazil test rate is 90ppm/day.
    No test positivity rate is practical.
    Vaccinations at 185% at 2500ppm/day
    - with 73% fully vaccinated.

    Peru detections at 105758ppm. (10.6%)
    Detection rate is 46ppm/day and falling.
    Fatalities are 6330ppm at 2.1ppm/day.
    FR is 6.0% from a 105405ppm detection recorded 7 days previously.
    Case FR short term is currently 1.8% .
    Peru test rate is 1430ppm/day.
    3.2% of tests are positive.
    Vaccinations at 187% at 4100ppm/day
    - with 73% fully vaccinated

    Chile detections at 166693ppm (16.7%)
    Detection rate is 1052ppm/day and falling.
    Fatalities are 2250ppm at 6.5ppm/day.
    FR is 1.5% from a 148414ppm detection recorded 14 days previously.
    Case FR short term is currently 0.4% .
    Chile test rate is 4350ppm/day.
    24.2% of current tests are positive.
    Vaccinations at 256% at 4600ppm/day
    - with 90% fully vaccinated.

    Argentina detections at 196091ppm (19.6%)
    Detection rate is 132ppm/day and falling.
    Fatalities are 2781ppm at 2.2ppm/day.
    FR is 1.4% from a 195089ppm detection recorded 7 days previously.
    Case FR short term is currently 1.0% .
    Argentina test rate is 590ppm/day.
    22.4% of tests are positive.
    Vaccinations at 206% at 2100ppm/day
    - with 79% fully vaccinated.

    Mexico detections at 42734ppm (4.3%)
    Detection rate is 64ppm/day and falling.
    Fatalities are 2456ppm at 1.9ppm/day.
    FR is 5.8% from a 42269ppm detection recorded 7 days previously.
    Case FR short term is currently 1.4% .
    Mexico test rate is 60ppm/day.
    No test positivity rate is practical.
    Vaccinations at 141% at 2100ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 61376ppm (6.1%)
    Detection rate is 26ppm/day and falling.
    Fatalities are 1659ppm at 0.5ppm/day.
    FR is 2.7% from a 61178ppm detection recorded 7 days previously.
    Case FR short term is currently 1.3%.
    SA test rate is 410ppm/day.
    6.3% of current tests are positive.
    Vaccinations at 53% at 1200ppm/day
    - with 29% fully vaccinated.(a rounding error?)

    Czech detections at 338671ppm (33.9%)
    Detection rate is 769ppm/day and falling.
    Fatalities are 3631ppm at 4.6ppm/day.
    FR is 1.1% from a 333285ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5% .
    Czech test rate is 3320ppm/day.
    23.2% of current tests are positive.
    Vaccinations at 162% at 400ppm/day
    - with 64% fully vaccinated.

    India detections at 30839ppm (3.1%)
    Detection rate is 4ppm/day and falling.
    Fatalities at 370ppm at 0.1ppm/day.
    FR is 1.2% from a 30805ppm detection recorded 7 days previously.
    Case FR short term is currently 1.2% .
    India test rate 620ppm/day.
    0.6% of current tests are positive.
    Vaccinations at 128% at 1500ppm/day
    - with 58% fully vaccinated.

    Israel detections at 396150ppm (39.6%)
    Detection rate is 709ppm/day and falling.
    Fatalities at 1110ppm at 1.8ppm/day.
    FR is 0.3% from a 390242ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 6610ppm/day.
    10.7% of current tests are positive
    Vaccinations at 194% at 100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Latvia - 9.3ppm/day
    Georgia - 8.4ppm/day
    Greenland - no data (8.0ppm/day)
    Lithuania - no data (8.0ppm/day)
    Hungary - 7.2ppm/day
    Denmark - 7.2ppm/day
    Bulgaria - 7.1ppm/day
    Estonia - 6.8ppm/day
    Chile - 6.5ppm/day
    Croatia - 5.8ppm/day
    Slovenia - 5.7ppm/day
    Greece - 5.3ppm/day
    Finland - 5.3ppm/day
    Macedonia - 5.2ppm/day
    Sweden - 5.2ppm/day
    Ukraine - no data (5.2ppm/day)
    Bosnia - 5.1ppm/day
    Russia - 5.1ppm/day


    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Mon Mar 14 18:51:06 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in eaerly 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220301_cases_ppm_report_group.jpg http://ve3ute.ca/query/220301_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220301_deaths_report_group.jpg http://ve3ute.ca/query/220301_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220301_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220301_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220301_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    A possible peaking in covid-omicron detections may be indicated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Mar07:

    US detections are at 238317ppm.(23.8%)
    Detection rate is 106ppm/day and falling.
    Fatalities are 2907ppm at 3.8ppm/day.
    FR is 1.2% from a 238317ppm detection recorded 7 days previously.
    Case FR short term is currently 2.3%.
    US test rate is 2520ppm/day
    4.2% of current tests are positive.
    Vaccinations at 168% at 400ppm/day
    - with 65% fully vaccinated.

    Canada detections at 88580ppm (8.9%) ~ 366 days behind the US.
    Detection rate at 134ppm/day and possibly leveling below 150ppm/day.
    Fatalities are 979ppm at 1.0ppm/day. ~ 441 days behind the US.
    FR is 1.1% from a 87851ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6%.
    Canada test rate is 1070ppm/day
    12.5% of current tests are positive.
    Vaccinations at 215% at 800ppm/day
    - with 81% fully vaccinated.

    Italy detections at 221530ppm. (22.2%)
    Detection rate is 821ppm/day and rising.
    Fatalities are 2599ppm at 2.3ppm/day.
    FR is 1.2% from a 216156ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4%.
    Italy test rate is 6500ppm/day.
    15.4% of current tests are positive.
    Vaccinations at 224% at 1100ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 242770ppm (24.3%)
    Detection rate is 149ppm/day and falling.
    Fatalities are 1752ppm at 4.0ppm/day.
    FR is 0.7% from a 241725ppm detection recorded 7 days previously.
    Case FR short term is currently 1.7%.
    Sweden test rate is 680ppm/day.
    21.9% of tests are positive.
    Vaccinations at 204% at 1900ppm/day
    - with 75% fully vaccinated.

    UK detections at 287163ppm. (28.7%)
    Detection rate is 868ppm/day and rising.
    Fatalities are 2388ppm at 1.5ppm/day.
    FR is 0.8% from a 282940ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3%.
    UK test rate is 10100ppm/day.
    8.6% of current tests are positive.
    Vaccinations at 206% at 600ppm/day
    - with 72% fully vaccinated.

    Brazil detections at 137270ppm. (13.7%)
    Detection rate is 212ppm/day and possibly leveling below 250ppm/day.
    Fatalities are 3063ppm at 2.0ppm/day
    FR is 2.3% from a 135882ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9% .
    Brazil test rate is 570ppm/day.
    No test positivity rate is practical.
    Vaccinations at 188% at 4600ppm/day
    - with 74% fully vaccinated.

    Peru detections at 106012ppm. (10.6%)
    Detection rate is 38ppm/day and falling.
    Fatalities are 6341ppm at 1.9ppm/day.
    FR is 6.0% from a 105758ppm detection recorded 7 days previously.
    Case FR short term is currently 1.9% .
    Peru test rate is 1270ppm/day.
    3.0% of tests are positive.
    Vaccinations at 190% at 3600ppm/day
    - with 74% fully vaccinated

    Chile detections at 171855ppm (17.2%)
    Detection rate is 842ppm/day and falling.
    Fatalities are 2284ppm at 6.0ppm/day.
    FR is 1.4% from a 158304ppm detection recorded 14 days previously.
    Case FR short term is currently 0.5% .
    Chile test rate is 4300ppm/day.
    19.6% of current tests are positive.
    Vaccinations at 257% at 3800ppm/day
    - with 90% fully vaccinated.

    Argentina detections at 196717ppm (19.7%)
    Detection rate is 109ppm/day and falling.
    Fatalities are 2789ppm at 1.3ppm/day.
    FR is 1.4% from a 196091ppm detection recorded 7 days previously.
    Case FR short term is currently 1.0% .
    Argentina test rate is 660ppm/day.
    16.5% of tests are positive.
    Vaccinations at 208% at 2800ppm/day
    - with 80% fully vaccinated.

    Mexico detections at 43043ppm (4.3%)
    Detection rate is 46ppm/day and falling.
    Fatalities are 2465ppm at 1.4ppm/day.
    FR is 5.8% from a 42734ppm detection recorded 7 days previously.
    Case FR short term is currently 2.1% .
    Mexico test rate is 50ppm/day.
    No test positivity rate is practical.
    Vaccinations at 143% at 3100ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 61532ppm (6.2%)
    Detection rate is 24ppm/day and falling.
    Fatalities are 1661ppm at 0.4ppm/day.
    FR is 2.7% from a 61376ppm detection recorded 7 days previously.
    Case FR short term is currently 1.5%.
    SA test rate is 400ppm/day.
    6.0% of current tests are positive.
    Vaccinations at 54% at 1200ppm/day
    - with 29% fully vaccinated.(a rounding error?)

    Czech detections at 343695ppm (34.4%)
    Detection rate is 752ppm/day and falling.
    Fatalities are 3651ppm at 3.1ppm/day.
    FR is 1.1% from a 338671ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Czech test rate is 2990ppm/day.
    25.2% of current tests are positive.
    Vaccinations at 163% at 300ppm/day
    - with 64% fully vaccinated.

    India detections at 30855ppm (3.1%)
    Detection rate is 3ppm/day and falling.
    Fatalities at 370ppm at 0.1ppm/day.
    FR is 1.2% from a 30839ppm detection recorded 7 days previously.
    Case FR short term is currently 1.4% .
    India test rate 600ppm/day.
    0.5% of current tests are positive.
    Vaccinations at 129% at 1300ppm/day
    - with 58% fully vaccinated.

    Israel detections at 400327ppm (40.0%)
    Detection rate is 712ppm/day and possibly leveling below 750ppm/day.
    Fatalities at 1117ppm at 1.5ppm/day.
    FR is 0.3% from a 396150ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2% .
    Israel test rate is 5890ppm/day.
    12.1% of current tests are positive
    Vaccinations at 194% at 100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Denmark - 7.5ppm/day
    Brunei - 7.4ppm/day
    Georgia - 6.8ppm/day
    Estonia - 6.8ppm/day
    Lithuania - 6.5ppm/day
    Latvia - 6.5ppm/day
    Chile - 6.0ppm/day
    Bulgaria - 5.5ppm/day
    Greece - 5.1ppm/day


    Denmark was one of the first countries to dismantle mitigation
    measures at the public level, six weeks ago.

    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate is now double the long-term
    average of record.



    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Mon Mar 21 15:04:00 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in eaerly 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220301_cases_ppm_report_group.jpg http://ve3ute.ca/query/220301_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220301_deaths_report_group.jpg http://ve3ute.ca/query/220301_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220301_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220301_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220301_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    A possible peaking in covid-omicron detections may be indicated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Mar21:

    US detections are at 239505ppm.(24.0%)
    Detection rate is 90ppm/day and falling.
    Fatalities are 2917ppm at NRppm/day (was 3.8ppm/day).
    FR is 1.2% from a 238869ppm detection recorded 7 days previously.
    Case FR short term is currently unreported (was 2.3%).
    US test rate is 1650ppm/day
    5.5% of current tests are positive.
    Vaccinations at 168% at 400ppm/day
    - with 65% fully vaccinated.

    Canada detections at 89494ppm (8.9%) ~ 360 days behind the US.
    Detection rate at 119ppm/day and possibly leveling below 140ppm/day.
    Fatalities are 978ppm (?) at 1.0ppm/day. ~ 454 days behind the US.
    FR is 1.1% from a 88580ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6%.
    Canada test rate is 1070ppm/day
    11.1% of current tests are positive.
    Vaccinations at 215% at 900ppm/day
    - with 82% fully vaccinated.

    Italy detections at 229623ppm. (23.0%)
    Detection rate is 1156ppm/day and rising.
    Fatalities are 2614ppm at 2.2ppm/day.
    FR is 1.2% from a 221530ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3%.
    Italy test rate is 6620ppm/day.
    17.5% of current tests are positive.
    Vaccinations at 224% at 900ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 243666ppm (24.4%)
    Detection rate is 128ppm/day and falling.
    Fatalities are 1777ppm at 3.4ppm/day.
    FR is 0.7% from a 242770ppm detection recorded 7 days previously.
    Case FR short term is currently 2.0%.
    Sweden test rate is unreported (was 680ppm/day).
    ~18.8% of current tests are positive.
    Vaccinations at 205% at 2100ppm/day
    - with 75% fully vaccinated.

    UK detections at 295487ppm. (29.5%)
    Detection rate is 1189ppm/day and rising.
    Fatalities are 2399ppm at 1.6ppm/day.
    FR is 0.8% from a 287163ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    UK test rate is 10100ppm/day.
    11.8% of current tests are positive.
    Vaccinations at 206% at 600ppm/day
    - with 72% fully vaccinated.

    Brazil detections at 138499ppm. (13.8%)
    Detection rate is 176ppm/day and falling.
    Fatalities are 3073ppm at 1.4ppm/day
    FR is 2.2% from a 137270ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Brazil test rate is 570ppm/day.
    No test positivity rate is practical.
    Vaccinations at 190% at 3200ppm/day
    - with 74% fully vaccinated.

    Peru detections at 106159ppm. (10.6%)
    Detection rate is 21ppm/day and falling.
    Fatalities are 6351ppm at 1.4ppm/day.
    FR is 6.0% from a 106012ppm detection recorded 7 days previously.
    Case FR short term is currently 3.7% .
    Peru test rate is 1270ppm/day.
    1.6% of tests are positive.
    Vaccinations at 194% at 3000ppm/day
    - with 76% fully vaccinated

    Chile detections at 176603ppm (17.7%)
    Detection rate is 678ppm/day and falling.
    Fatalities are 2317ppm at 4.8ppm/day.
    FR is 1.4% from a 166693ppm detection recorded 14 days previously.
    Case FR short term is currently 0.5% .
    Chile test rate is 4260ppm/day.
    15.9% of current tests are positive.
    Vaccinations are unreported (257% at 3800ppm/day)
    - with ~90% fully vaccinated.

    Argentina detections at 197513ppm (19.8%)
    Detection rate is 114ppm/day and possibly leveling below 140ppm/day.
    Fatalities are 2796ppm at 1.0ppm/day.
    FR is 1.4% from a 196717ppm detection recorded 7 days previously.
    Case FR short term is currently 0.8% .
    Argentina test rate is 660ppm/day.
    17.3% of tests are positive.
    Vaccinations at 210% at 2300ppm/day
    - with 80% fully vaccinated.

    Mexico detections at 43251ppm (4.3%)
    Detection rate is 30ppm/day and falling.
    Fatalities are 2473ppm at 1.1ppm/day.
    FR is 5.7% from a 43043ppm detection recorded 7 days previously.
    Case FR short term is currently 1.7% .
    Mexico test rate is 50ppm/day.
    No test positivity rate is practical.
    Vaccinations at 144% at 2700ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 61694ppm (6.2%)
    Detection rate is 23ppm/day and leveling below 30ppm/day.
    Fatalities are 1664ppm at 0.4ppm/day.
    FR is 2.7% from a 61532ppm detection recorded 7 days previously.
    Case FR short term is currently 1.5%.
    SA test rate is 390ppm/day.
    5.9% of current tests are positive.
    Vaccinations at 55% at 1100ppm/day
    - with 29% fully vaccinated.(a rounding error?)

    Czech detections at 348536ppm (34.9%)
    Detection rate is 692ppm/day and falling.
    Fatalities are 3670ppm at 2.7ppm/day.
    FR is 1.1% from a 343695ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Czech test rate is 2990ppm/day.
    23.1% of current tests are positive.
    Vaccinations at 163% at 300ppm/day
    - with 64% fully vaccinated.

    India detections at 30866ppm (3.1%)
    Detection rate is 2ppm/day and falling.
    Fatalities at 371ppm at 0.1ppm/day.
    FR is 1.2% from a 30855ppm detection recorded 7 days previously.
    Case FR short term is currently 1.9% .
    India test rate 580ppm/day.
    0.3% of current tests are positive.
    Vaccinations at 130% at 1100ppm/day
    - with 59% fully vaccinated.

    Israel detections at 406065ppm (40.6%)
    Detection rate is 820ppm/day and rising.
    Fatalities at 1123ppm at 0.8ppm/day.
    FR is 0.3% from a 400327ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 5290ppm/day.
    15.5% of current tests are positive
    Vaccinations at 194% at 100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Norway - 10.9ppm/day
    Brunei - 7.4ppm/day
    S.Korea - 6.0ppm/day
    Latvia - 5.7ppm/day
    Denmark - 5.6ppm/day
    Finland - 5.4ppm/day
    Greece - 5.2ppm/day
    Lithuania - 5.0ppm/day
    Slovakia - 5.0ppm/day


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this is
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate is now double the long-term
    average of record.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Denmark was one of the first countries to dismantle mitigation
    measures at the public level, six weeks ago, resulting in it's
    (and Greenland's) subsequent appearance as a fatality hotspot.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From M Kfivethousand@21:1/5 to legg on Thu Mar 24 18:35:46 2022
    On Monday, March 21, 2022 at 2:03:36 PM UTC-5, legg wrote:
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in eaerly 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.

    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220301_cases_ppm_report_group.jpg http://ve3ute.ca/query/220301_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220301_deaths_report_group.jpg http://ve3ute.ca/query/220301_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_worl_map.jpg http://ve3ute.ca/query/220301_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220301_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220301_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'. http://ve3ute.ca/query/flu_season_029c.jpg
    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    A possible peaking in covid-omicron detections may be indicated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.
    As of Mar21:

    US detections are at 239505ppm.(24.0%)
    Detection rate is 90ppm/day and falling.
    Fatalities are 2917ppm at NRppm/day (was 3.8ppm/day).
    FR is 1.2% from a 238869ppm detection recorded 7 days previously.
    Case FR short term is currently unreported (was 2.3%).
    US test rate is 1650ppm/day
    5.5% of current tests are positive.
    Vaccinations at 168% at 400ppm/day
    - with 65% fully vaccinated.
    Canada detections at 89494ppm (8.9%) ~ 360 days behind the US.
    Detection rate at 119ppm/day and possibly leveling below 140ppm/day. Fatalities are 978ppm (?) at 1.0ppm/day. ~ 454 days behind the US.
    FR is 1.1% from a 88580ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6%.
    Canada test rate is 1070ppm/day
    11.1% of current tests are positive.
    Vaccinations at 215% at 900ppm/day
    - with 82% fully vaccinated.

    Italy detections at 229623ppm. (23.0%)
    Detection rate is 1156ppm/day and rising.
    Fatalities are 2614ppm at 2.2ppm/day.
    FR is 1.2% from a 221530ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3%.
    Italy test rate is 6620ppm/day.
    17.5% of current tests are positive.
    Vaccinations at 224% at 900ppm/day.
    - with 79% fully vaccinated.
    Sweden detections at 243666ppm (24.4%)
    Detection rate is 128ppm/day and falling.
    Fatalities are 1777ppm at 3.4ppm/day.
    FR is 0.7% from a 242770ppm detection recorded 7 days previously.
    Case FR short term is currently 2.0%.
    Sweden test rate is unreported (was 680ppm/day).
    ~18.8% of current tests are positive.
    Vaccinations at 205% at 2100ppm/day
    - with 75% fully vaccinated.
    UK detections at 295487ppm. (29.5%)
    Detection rate is 1189ppm/day and rising.
    Fatalities are 2399ppm at 1.6ppm/day.
    FR is 0.8% from a 287163ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    UK test rate is 10100ppm/day.
    11.8% of current tests are positive.
    Vaccinations at 206% at 600ppm/day
    - with 72% fully vaccinated.
    Brazil detections at 138499ppm. (13.8%)
    Detection rate is 176ppm/day and falling.
    Fatalities are 3073ppm at 1.4ppm/day
    FR is 2.2% from a 137270ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Brazil test rate is 570ppm/day.
    No test positivity rate is practical.
    Vaccinations at 190% at 3200ppm/day
    - with 74% fully vaccinated.

    Peru detections at 106159ppm. (10.6%)
    Detection rate is 21ppm/day and falling.
    Fatalities are 6351ppm at 1.4ppm/day.
    FR is 6.0% from a 106012ppm detection recorded 7 days previously.
    Case FR short term is currently 3.7% .
    Peru test rate is 1270ppm/day.
    1.6% of tests are positive.
    Vaccinations at 194% at 3000ppm/day
    - with 76% fully vaccinated

    Chile detections at 176603ppm (17.7%)
    Detection rate is 678ppm/day and falling.
    Fatalities are 2317ppm at 4.8ppm/day.
    FR is 1.4% from a 166693ppm detection recorded 14 days previously.
    Case FR short term is currently 0.5% .
    Chile test rate is 4260ppm/day.
    15.9% of current tests are positive.
    Vaccinations are unreported (257% at 3800ppm/day)
    - with ~90% fully vaccinated.

    Argentina detections at 197513ppm (19.8%)
    Detection rate is 114ppm/day and possibly leveling below 140ppm/day. Fatalities are 2796ppm at 1.0ppm/day.
    FR is 1.4% from a 196717ppm detection recorded 7 days previously.
    Case FR short term is currently 0.8% .
    Argentina test rate is 660ppm/day.
    17.3% of tests are positive.
    Vaccinations at 210% at 2300ppm/day
    - with 80% fully vaccinated.

    Mexico detections at 43251ppm (4.3%)
    Detection rate is 30ppm/day and falling.
    Fatalities are 2473ppm at 1.1ppm/day.
    FR is 5.7% from a 43043ppm detection recorded 7 days previously.
    Case FR short term is currently 1.7% .
    Mexico test rate is 50ppm/day.
    No test positivity rate is practical.
    Vaccinations at 144% at 2700ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 61694ppm (6.2%)
    Detection rate is 23ppm/day and leveling below 30ppm/day.
    Fatalities are 1664ppm at 0.4ppm/day.
    FR is 2.7% from a 61532ppm detection recorded 7 days previously.
    Case FR short term is currently 1.5%.
    SA test rate is 390ppm/day.
    5.9% of current tests are positive.
    Vaccinations at 55% at 1100ppm/day
    - with 29% fully vaccinated.(a rounding error?)
    Czech detections at 348536ppm (34.9%)
    Detection rate is 692ppm/day and falling.
    Fatalities are 3670ppm at 2.7ppm/day.
    FR is 1.1% from a 343695ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Czech test rate is 2990ppm/day.
    23.1% of current tests are positive.
    Vaccinations at 163% at 300ppm/day
    - with 64% fully vaccinated.
    India detections at 30866ppm (3.1%)
    Detection rate is 2ppm/day and falling.
    Fatalities at 371ppm at 0.1ppm/day.
    FR is 1.2% from a 30855ppm detection recorded 7 days previously.
    Case FR short term is currently 1.9% .
    India test rate 580ppm/day.
    0.3% of current tests are positive.
    Vaccinations at 130% at 1100ppm/day
    - with 59% fully vaccinated.

    Israel detections at 406065ppm (40.6%)
    Detection rate is 820ppm/day and rising.
    Fatalities at 1123ppm at 0.8ppm/day.
    FR is 0.3% from a 400327ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 5290ppm/day.
    15.5% of current tests are positive
    Vaccinations at 194% at 100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :
    Norway - 10.9ppm/day
    Brunei - 7.4ppm/day
    S.Korea - 6.0ppm/day
    Latvia - 5.7ppm/day
    Denmark - 5.6ppm/day
    Finland - 5.4ppm/day
    Greece - 5.2ppm/day
    Lithuania - 5.0ppm/day
    Slovakia - 5.0ppm/day
    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this is
    part of their testing protocol.
    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate is now double the long-term
    average of record.
    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.
    Denmark was one of the first countries to dismantle mitigation
    measures at the public level, six weeks ago, resulting in it's
    (and Greenland's) subsequent appearance as a fatality hotspot.
    Doses applied in Israel, Chile and other highly vaccinated countries appear to be providing 3rd dose booster reinforcement, without contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.


    Somebody deliver some tylenol, juice

    mk5000

    I want to play a psycho, something more challenging than just ‘the girlfriend’ part.

    Barbara Palvin

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Tue Mar 29 10:12:30 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220301_cases_ppm_report_group.jpg http://ve3ute.ca/query/220301_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220301_deaths_report_group.jpg http://ve3ute.ca/query/220301_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220301_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220301_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220301_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220301_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Mar28:

    US detections are at 240288ppm.(24.0%)
    Detection rate is 92ppm/day and possibly leveling below 100ppm/day.
    Fatalities are 2938ppm at 2.3ppm/day.
    FR is 1.2% from a 239505ppm detection recorded 7 days previously.
    Case FR short term is currently 2.3%.
    US test rate is unreported (~2030ppm/day).
    No test positivity rate is practical.
    Vaccinations at 169% at 400ppm/day
    - with 65% fully vaccinated.

    Canada detections at 90879ppm (9.1%) ~ 321 days behind the US.
    Detection rate at 174ppm/day and rising.
    Fatalities are 985ppm at 1.0ppm/day. ~ 461 days behind the US.
    FR is 1.1% from a 89494ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9%.
    Canada test rate is 950ppm/day
    18.3% of current tests are positive.
    Vaccinations at 216% at 700ppm/day
    - with 82% fully vaccinated.

    Italy detections at 238477ppm. (23.8%)
    Detection rate is 1186ppm/day and rising.
    Fatalities are 2632ppm at 2.3ppm/day.
    FR is 1.1% from a 229623ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    Italy test rate is 7840ppm/day.
    15.1% of current tests are positive.
    Vaccinations at 225% at 700ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 244262ppm (24.4%)
    Detection rate is 113ppm/day and falling.
    Fatalities are 1790ppm at 2.7ppm/day.
    FR is 0.7% from a 243666ppm detection recorded 7 days previously.
    Case FR short term is currently 1.8%.
    Sweden test rate is 570ppm/day.
    19.8% of current tests are positive.
    Vaccinations at 207% at 2000ppm/day
    - with 75% fully vaccinated.

    UK detections at 307467ppm. (30.7%)
    Detection rate is 1238ppm/day and rising.
    Fatalities are 2416ppm at 2.1ppm/day.
    FR is 0.8% from a 295487ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    UK test rate is 10860ppm/day.
    11.4% of current tests are positive.
    Vaccinations at 207% at 500ppm/day
    - with 72% fully vaccinated.

    Brazil detections at 139526ppm. (14.0%)
    Detection rate is 139ppm/day and falling.
    Fatalities are 3081ppm at 1.1ppm/day
    FR is 2.2% from a 138499ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 193% at 2600ppm/day
    - with 75% fully vaccinated.

    Peru detections at 106286ppm. (10.6%)
    Detection rate is 16ppm/day and falling.
    Fatalities are 6360ppm at 1.0ppm/day.
    FR is 6.0% from a 106159ppm detection recorded 7 days previously.
    Case FR short term is currently 4.3% .
    Peru test rate is 1340ppm/day.
    1.2% of tests are positive.
    Vaccinations at 196% at 3000ppm/day
    - with 76% fully vaccinated

    Chile detections at 179835ppm (18.0%)
    Detection rate is 401ppm/day and falling.
    Fatalities are 2938ppm (Mar21 correction upwards) at 3.6ppm/day.
    FR is 1.7% from a 171855ppm detection recorded 14 days previously.
    Case FR short term is currently 0.5% .
    Chile test rate is 4130ppm/day.
    9.7% of current tests are positive.
    Vaccinations at 262% at 2900ppm/day.
    - with 90% fully vaccinated.

    Argentina detections at 197973ppm (19.8%)
    Detection rate is 54ppm/day and falling.
    Fatalities are 2805ppm at 1.1ppm/day.
    FR is 1.4% from a 197513ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9% .
    Argentina test rate is 460ppm/day.
    11.7% of tests are positive.
    Vaccinations at 211% at 1200ppm/day
    - with 81% fully vaccinated.

    Mexico detections at 43386ppm (4.3%)
    Detection rate is 18ppm/day and falling.
    Fatalities are 2478ppm at 0.7ppm/day.
    FR is 5.7% from a 43251ppm detection recorded 7 days previously.
    Case FR short term is currently 2.0% .
    Mexico test rate is 40ppm/day.
    No test positivity rate is practical.
    Vaccinations at 146% at 1700ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 61854ppm (6.2%)
    Detection rate is 22ppm/day and leveling below 30ppm/day.
    Fatalities are 1665ppm at 0.2ppm/day.
    FR is 2.7% from a 61694ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9%.
    SA test rate is 380ppm/day.
    5.8% of current tests are positive.
    Vaccinations at 56% at 900ppm/day
    - with 30% fully vaccinated.(a rounding error?)

    Czech detections at 354249ppm (35.4%)
    Detection rate is 786ppm/day and rising.
    Fatalities are 3693ppm at 3.1ppm/day.
    FR is 1.1% from a 348536ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Czech test rate is 2520ppm/day.
    31.2% of current tests are positive.
    Vaccinations at 163% at 300ppm/day
    - with 64% fully vaccinated.

    India detections at 30875ppm (3.1%)
    Detection rate is 1ppm/day and falling.
    Fatalities at 374ppm at 0.5ppm/day.
    FR is 1.2% from a 30866ppm detection recorded 7 days previously.
    Case FR short term is currently 1.9% .
    India test rate 420ppm/day.
    0.2% of current tests are positive.
    Vaccinations at 132% at 2000ppm/day
    - with 59% fully vaccinated.

    Israel detections at 417190ppm (41.7%)
    Detection rate is 1389ppm/day and rising.
    Fatalities at 1129ppm at 0.8ppm/day.
    FR is 0.3% from a 406065ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 7380ppm/day.
    18.8% of current tests are positive
    Vaccinations at 194% at 200ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    S.Korea - 6.4ppm/day
    Lithuania - 5.6ppm/day
    Estonia - 5.1ppm/day


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate is now double the long-term
    average of record.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Denmark was one of the first countries to dismantle mitigation
    measures at the public level, six weeks ago, resulting in it's
    (and Greenland's) subsequent appearance as a fatality hotspot.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Tue Apr 5 22:16:52 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Apr04:

    US detections are at 240768ppm.(24.1%)
    Detection rate is 84ppm/day and possibly leveling below 100ppm/day.
    Fatalities are 2951ppm at 2.4ppm/day.
    FR is 1.2% from a 240288ppm detection recorded 7 days previously.
    Case FR short term is currently 2.8%.
    US test rate is 1790ppm/day.
    4.7% of current tests are positive.
    Vaccinations at 169% at 400ppm/day
    - with 66% fully vaccinated.

    Canada detections at 92174ppm (9.2%) ~ 367 days behind the US.
    Detection rate at 208ppm/day and rising.
    Fatalities are 991ppm at 1.0ppm/day. ~ 462 days behind the US.
    FR is 1.1% from a 90879ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6%.
    Canada test rate is 1110ppm/day
    18.7% of current tests are positive.
    Vaccinations at 216% at 800ppm/day
    - with 82% fully vaccinated.

    Italy detections at 245824ppm. (24.6%)
    Detection rate is 1138ppm/day and possibly leveling below 1200ppm/day. Fatalities are 2647ppm at 2.3ppm/day.
    FR is 1.1% from a 238477ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    Italy test rate is 7670ppm/day.
    14.8% of current tests are positive.
    Vaccinations at 225% at 500ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 244863ppm (24.5%)
    Detection rate is 86ppm/day and falling.
    Fatalities are 1808ppm at 2.5ppm/day.
    FR is 0.7% from a 244262ppm detection recorded 7 days previously.
    Case FR short term is currently 1.9%.
    Sweden test rate is 1600ppm/day.
    5.4% of current tests are positive.
    Vaccinations at 208% at 1600ppm/day
    - with 75% fully vaccinated.

    UK detections at 307467ppm. (30.7%)
    Detection rate is 1238ppm/day and rising.
    Fatalities are 2416ppm at 2.1ppm/day.
    FR is 0.8% from a 307467ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    UK test rate is 10860ppm/day.
    11.4% of current tests are positive.
    Vaccinations at 207% at 500ppm/day
    - with 72% fully vaccinated.

    Brazil detections at 140204ppm. (14.0%)
    Detection rate is 102ppm/day and falling.
    Fatalities are 3086ppm at 0.9ppm/day
    FR is 2.2% from a 139526ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 194% at 3100ppm/day
    - with 75% fully vaccinated.

    Peru detections at 106374ppm. (10.6%)
    Detection rate is 14ppm/day and falling.
    Fatalities are 6365ppm at 0.8ppm/day.
    FR is 6.0% from a 106286ppm detection recorded 7 days previously.
    Case FR short term is currently 4.6% .
    Peru test rate is 1440ppm/day.
    1.0% of tests are positive.
    Vaccinations at 198% at 3500ppm/day
    - with 77% fully vaccinated

    Chile detections at 181480ppm (18.1%)
    Detection rate is 272ppm/day and falling.
    Fatalities are 2954ppm at 2.9ppm/day.
    FR is 1.7% from a 176603ppm detection recorded 14 days previously.
    Case FR short term is currently 0.5% .
    Chile test rate is 4130ppm/day.
    6.6% of current tests are positive.
    Vaccinations at 264% at 2500ppm/day.
    - with 90% fully vaccinated.

    Argentina detections at 197973ppm (19.8%)
    Detection rate is 54ppm/day and falling.
    Fatalities are 2805ppm at 1.1ppm/day.
    FR is 1.4% from a 197973ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9% .
    Argentina test rate is 460ppm/day.
    11.7% of tests are positive.
    Vaccinations at 211% at 1200ppm/day
    - with 81% fully vaccinated.

    Mexico detections at 43499ppm (4.3%)
    Detection rate is 17ppm/day and falling.
    Fatalities are 2481ppm at 0.6ppm/day.
    FR is 5.7% from a 43386ppm detection recorded 7 days previously.
    Case FR short term is currently 3.1% .
    Mexico test rate is 40ppm/day.
    No test positivity rate is practical.
    Vaccinations at 147% at 3300ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 62006ppm (6.2%)
    Detection rate is 23ppm/day and leveling below 30ppm/day.
    Fatalities are 1666ppm at 0.2ppm/day.
    FR is 2.7% from a 61854ppm detection recorded 7 days previously.
    Case FR short term is currently 1.0%.
    SA test rate is 390ppm/day.
    5.9% of current tests are positive.
    Vaccinations at 56% at 1100ppm/day
    - with 30% fully vaccinated.(a rounding error?)

    Czech detections at 357338ppm (35.7%)
    Detection rate is 559ppm/day and falling.
    Fatalities are 3704ppm at 2.5ppm/day.
    FR is 1.1% from a 354249ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3% .
    Czech test rate is 2370ppm/day.
    23.6% of current tests are positive.
    Vaccinations at 163% at 300ppm/day
    - with 64% fully vaccinated.

    India detections at 30880ppm (3.1%)
    Detection rate is 1ppm/day and leveling below 2ppm/day.
    Fatalities at 374ppm at 0.0ppm/day.
    FR is 1.2% from a 30875ppm detection recorded 7 days previously.
    Case FR short term is currently 2.6% .
    India test rate 390ppm/day.
    0.3% of current tests are positive.
    Vaccinations at 132% at 1700ppm/day
    - with 60% fully vaccinated.

    Israel detections at 424743ppm (42.5%)
    Detection rate is 1263ppm/day and possibly leveling below 1300ppm/day. Fatalities at 1133ppm at 0.9ppm/day.
    FR is 0.3% from a 417190ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 6880ppm/day.
    18.4% of current tests are positive
    Vaccinations at 195% at 300ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    S.Korea - 6.3ppm/day
    Greece - 5.7ppm/day
    Latvia - 5.2ppm/day
    Austria - 5.1ppm/day


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate is now double the long-term
    average of record.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Denmark was one of the first countries to dismantle mitigation
    measures at the public level, six weeks ago, resulting in it's
    (and Greenland's) subsequent appearance as a fatality hotspot.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Wed Apr 6 11:50:35 2022
    On Tue, 05 Apr 2022 22:16:52 -0400, legg <legg@nospam.magma.ca> wrote:

    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Apr01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_031c.jpg


    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz

    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. >> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.

    Comparison charts, as of Apr01 are available:

    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg
    http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg
    http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg
    http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg
    http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg
    http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg
    http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Tue Apr 12 00:50:22 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Apr11:

    US detections are at 241552ppm.(24.2%)
    Detection rate is 108ppm/day and rising.
    Fatalities are 2960ppm at 1.6ppm/day.
    FR is 1.2% from a 240768ppm detection recorded 7 days previously.
    Case FR short term is currently 1.7%.
    US test rate is 1910ppm/day.
    5.7% of current tests are positive.
    Vaccinations at 170% at 1000ppm/day
    - with 66% fully vaccinated.

    Canada detections at 93136ppm (9.3%) ~ 369 days behind the US.
    Detection rate at 147ppm/day and possibly leveling below 180ppm/day.
    Fatalities are 996ppm at 0.8ppm/day. ~ 462 days behind the US.
    FR is 1.1% from a 92174ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4%.
    Canada test rate is 1460ppm/day
    10.1% of current tests are positive.
    Vaccinations at 216% at 900ppm/day
    - with 82% fully vaccinated.

    Italy detections at 253316ppm. (25.3%)
    Detection rate is 1056ppm/day and possibly leveling below 1200ppm/day. Fatalities are 2663ppm at 2.8ppm/day.
    FR is 1.1% from a 245824ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    Italy test rate is 9790ppm/day.
    10.8% of current tests are positive.
    Vaccinations at 226% at 400ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 245270ppm (24.5%)
    Detection rate is 58ppm/day and falling.
    Fatalities are 1821ppm at 2.0ppm/day.
    FR is 0.7% from a 244863ppm detection recorded 7 days previously.
    Case FR short term is currently 2.3%.
    Sweden test rate is 1500ppm/day.
    3.9% of current tests are positive.
    Vaccinations are unreported at ~1500ppm/day
    - with 75% fully vaccinated.

    UK detections at 316473ppm. (31.6%)
    Detection rate is 700ppm/day and falling.
    Fatalities are 2491ppm at 2.3ppm/day.
    FR is 0.8% from a 307467ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    UK test rate is 7880ppm/day.
    8.8% of current tests are positive.
    Vaccinations at 207% at 500ppm/day
    - with 73% fully vaccinated.

    Brazil detections at 140911ppm. (14.1%)
    Detection rate is 101ppm/day and falling.
    Fatalities are 3091ppm at 0.7ppm/day
    FR is 2.2% from a 140204ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 197% at 2900ppm/day
    - with 76% fully vaccinated.

    Peru detections at 106463ppm. (10.6%)
    Detection rate is 13ppm/day and falling.
    Fatalities are 6370ppm at 0.7ppm/day.
    FR is 6.0% from a 106374ppm detection recorded 7 days previously.
    Case FR short term is currently 5.4% .
    Peru test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 206% at 3800ppm/day
    - with 79% fully vaccinated

    Chile detections at 182800ppm (18.2%)
    Detection rate is 189ppm/day and falling.
    Fatalities are 2964ppm at 2.2ppm/day.
    FR is 1.7% from a 179835ppm detection recorded 14 days previously.
    Case FR short term is currently 0.7% .
    Chile test rate is 2990ppm/day.
    6.3% of current tests are positive.
    Vaccinations at 266% at 2400ppm/day.
    - with 91% fully vaccinated.

    Argentina detections at 198415ppm (19.8%)
    Detection rate is 36ppm/day and falling.
    Fatalities are 2811ppm at 0.4ppm/day.
    FR is 1.4% from a 197973ppm detection recorded 7 days previously.
    Case FR short term is currently 0.8% .
    Argentina test rate is 350ppm/day.
    10.3% of tests are positive.
    Vaccinations at 213% at 1000ppm/day
    - with 81% fully vaccinated.

    Mexico detections at 43934ppm (4.4%)
    Detection rate is 62ppm/day and rising.
    Fatalities are 2485ppm at 0.6ppm/day.
    FR is 5.7% from a 43499ppm detection recorded 7 days previously.
    Case FR short term is currently 2.6% .
    Mexico test rate is 40ppm/day.
    No test positivity rate is practical.
    Vaccinations are unreported (~147%) .
    - with ~61% fully vaccinated.

    South Africa detections at 62158ppm (6.2%)
    Detection rate is 22ppm/day and leveling below 30ppm/day.
    Fatalities are 1667ppm at 0.2ppm/day.
    FR is 2.7% from a 62006ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6%.
    SA test rate is 360ppm/day.
    6.1% of current tests are positive.
    Vaccinations at 57% at 600ppm/day
    - with 30% fully vaccinated.(a rounding error?)

    Czech detections at 360138ppm (36.0%)
    Detection rate is 422ppm/day and falling.
    Fatalities are 3719ppm at 2.1ppm/day.
    FR is 1.1% from a 357338ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Czech test rate is 1990ppm/day.
    21.2% of current tests are positive.
    Vaccinations at 163% at 200ppm/day
    - with 64% fully vaccinated.

    India detections at 30886ppm (3.1%)
    Detection rate is 1ppm/day and leveling below 2ppm/day.
    Fatalities at 374ppm at 0.0ppm/day.
    FR is 1.2% from a 30880ppm detection recorded 7 days previously.
    Case FR short term is currently 3.5% .
    India test rate 320ppm/day.
    0.3% of current tests are positive.
    Vaccinations at 133% at 1100ppm/day
    - with 60% fully vaccinated.

    Israel detections at 430293ppm (43.0%)
    Detection rate is 793ppm/day and falling.
    Fatalities at 1139ppm at 0.8ppm/day.
    FR is 0.3% from a 424743ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 5530ppm/day.
    14.3% of current tests are positive
    Vaccinations at 195% at 200ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    S.Korea - 6.2ppm/day
    Greece - 6.2ppm/day
    Malta - 5.8ppm/day
    Cyprus - 5.6ppm/day


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate is now double the long-term
    average of record.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Denmark was one of the first countries to dismantle mitigation
    measures at the public level, six weeks ago, resulting in it's
    (and Greenland's) subsequent appearance as a fatality hotspot.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Wed Apr 20 08:44:20 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Apr18:

    US detections are at 242363ppm.(24.2%)
    Detection rate is 101ppm/day and falling.
    Fatalities are 2970ppm at 1.3ppm/day.
    FR is 1.2% from a 241552ppm detection recorded 7 days previously.
    Case FR short term is currently 2.5%.
    US test rate is 2120ppm/day.
    4.8% of current tests are positive.
    Vaccinations at 171% at 1000ppm/day
    - with 66% fully vaccinated.

    Canada detections at 95825ppm (9.6%) ~ 363 days behind the US.
    Detection rate at 414ppm/day and rising.
    Fatalities are 1009ppm at 1.9ppm/day. ~ 467 days behind the US.
    FR is 1.1% from a 93136ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5%.
    Canada test rate is 1350ppm/day
    30.7% of current tests are positive.
    Vaccinations at 217% at 1600ppm/day
    - with 82% fully vaccinated.

    Italy detections at 260582ppm. (26.1%)
    Detection rate is 970ppm/day and falling.
    Fatalities are 2680ppm at 2.1ppm/day.
    FR is 1.1% from a 253316ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3%.
    Italy test rate is 6560ppm/day.
    14.8% of current tests are positive.
    Vaccinations at 226% at 300ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 245665ppm (24.6%)
    Detection rate is 56ppm/day and falling.
    Fatalities are 1831ppm at 2.0ppm/day.
    FR is 0.7% from a 245270ppm detection recorded 7 days previously.
    Case FR short term is currently 2.0%.
    Sweden test rate is 400ppm/day.
    14.0% of current tests are positive.
    Vaccinations at 212% at 3400ppm/day
    - with 75% fully vaccinated.

    UK detections at 319906ppm. (32.0%)
    Detection rate is 507ppm/day and falling.
    Fatalities are 2515ppm at 4.2ppm/day.
    FR is 0.8% from a 316473ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    UK test rate is 6240ppm/day.
    8.1% of current tests are positive.
    Vaccinations at 208% at 700ppm/day
    - with 73% fully vaccinated.

    Brazil detections at 141411ppm. (14.1%)
    Detection rate is 66ppm/day and falling.
    Fatalities are 3095ppm at 0.7ppm/day
    FR is 2.2% from a 140911ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 198% at 1800ppm/day
    - with 76% fully vaccinated.

    Peru detections at 106608ppm. (10.7%)
    Detection rate is 20ppm/day and leveling below 25ppm/day.
    Fatalities are 6375ppm at 0.6ppm/day.
    FR is 6.0% from a 106463ppm detection recorded 7 days previously.
    Case FR short term is currently 3.2% .
    Peru test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 207% at 3800ppm/day
    - with 79% fully vaccinated

    Chile detections at 183815ppm (18.4%)
    Detection rate is 128ppm/day and falling.
    Fatalities are 2981ppm at 1.4ppm/day.
    FR is 1.6% from a 181480ppm detection recorded 14 days previously.
    Case FR short term is currently 0.4% .
    Chile test rate is 2470ppm/day.
    5.2% of current tests are positive.
    Vaccinations at 268% at 2470ppm/day.
    - with 91% fully vaccinated.

    Argentina detections at 198679ppm (19.9%)
    Detection rate is 26ppm/day and falling.
    Fatalities are 2814ppm at 0.5ppm/day.
    FR is 1.4% from a 198415ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9% .
    Argentina test rate is 230ppm/day.
    11.3% of tests are positive.
    Vaccinations at 214% at 700ppm/day
    - with 81% fully vaccinated.

    Mexico detections at 43970ppm (4.4%)
    Detection rate is 5ppm/day and falling.
    Fatalities are 2487ppm at 0.2ppm/day.
    FR is 5.7% from a 43934ppm detection recorded 7 days previously.
    Case FR short term is currently 2.2% .
    Mexico test rate is 20ppm/day.
    No test positivity rate is practical.
    Vaccinations at 149% at 1700ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 62325ppm (6.2%)
    Detection rate is 23ppm/day and leveling below 30ppm/day.
    Fatalities are 1669ppm at 0.2ppm/day.
    FR is 2.7% from a 62158ppm detection recorded 7 days previously.
    Case FR short term is currently 1.5%.
    SA test rate is 310ppm/day.
    3.8% of current tests are positive.
    Vaccinations at 57% at 500ppm/day
    - with 30% fully vaccinated.(a rounding error?)

    Czech detections at 362092ppm (36.2%)
    Detection rate is 197ppm/day and falling.
    Fatalities are 3729ppm at 1.1ppm/day.
    FR is 1.0% from a 360138ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Czech test rate is 1460ppm/day.
    13.9% of current tests are positive.
    Vaccinations at 164% at 100ppm/day
    - with 64% fully vaccinated.

    India detections at 30892ppm (3.1%)
    Detection rate is 1ppm/day and leveling below 2ppm/day.
    Fatalities at 375ppm at 0.0ppm/day.
    FR is 1.2% from a 30886ppm detection recorded 7 days previously.
    Case FR short term is currently 1.5% .
    India test rate 390ppm/day.
    0.3% of current tests are positive.
    Vaccinations at 134% at 800ppm/day
    - with 61% fully vaccinated.

    Israel detections at 434472ppm (43.4%)
    Detection rate is 459ppm/day and falling.
    Fatalities at 1146ppm at 0.9ppm/day.
    FR is 0.3% from a 430293ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 5270ppm/day.
    8.7% of current tests are positive
    Vaccinations at 195% at 100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Greece - 6.2ppm/day



    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate is now double the long-term
    average of record.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.


    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.


    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Mon Apr 25 21:36:44 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:

    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    As of Apr25:

    US detections are at 243260ppm.(24.3%)
    Detection rate is 151ppm/day and leveling below 200ppm/day.
    Fatalities are 2978ppm at 1.1ppm/day.
    FR is 1.2% from a 242363ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9%.
    US test rate is 1630ppm/day.
    9.3% of current tests are positive.
    Vaccinations at 172% at 900ppm/day
    - with 66% fully vaccinated.

    Canada detections at 97363ppm (9.7%) ~ 360 days behind the US.
    Detection rate at 265ppm/day and possibly leveling below 300ppm/day.
    Fatalities are 1021ppm at 1.8ppm/day. ~ 471 days behind the US.
    FR is 1.1% from a 95825ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5%.
    Canada test rate is 1230ppm/day
    21.5% of current tests are positive.
    Vaccinations at 219% at 2100ppm/day
    - with 82% fully vaccinated.

    Italy detections at 267297ppm. (26.7%)
    Detection rate is 1004ppm/day and possibly leveling below 1200ppm/day. Fatalities are 2695ppm at 2.4ppm/day.
    FR is 1.1% from a 260582ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    Italy test rate is 5970ppm/day.
    16.8% of current tests are positive.
    Vaccinations at 227% at 500ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 245900ppm (24.6%)
    Detection rate is 34ppm/day and falling.
    Fatalities are 1839ppm at 1.2ppm/day.
    FR is 0.7% from a 245665ppm detection recorded 7 days previously.
    Case FR short term is currently 2.0%.
    Sweden test rate is 320ppm/day.
    10.6% of current tests are positive.
    Vaccinations at 213% at 2000ppm/day
    - with 75% fully vaccinated.

    UK detections at 322646ppm. (32.3%)
    Detection rate is 391ppm/day and falling.
    Fatalities are 2544ppm at 4.1ppm/day.
    FR is 0.8% from a 319906ppm detection recorded 7 days previously.
    Case FR short term is currently 0.7%.
    UK test rate is 4880ppm/day.
    8.0% of current tests are positive.
    Vaccinations at 208% at 500ppm/day
    - with 73% fully vaccinated.

    Brazil detections at 141824ppm. (14.2%)
    Detection rate is 65ppm/day and leveling below 80ppm/day.
    Fatalities are 3098ppm at 0.5ppm/day
    FR is 2.2% from a 141411ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 199% at 1800ppm/day
    - with 76% fully vaccinated.

    Peru detections at 106743ppm. (10.7%)
    Detection rate is 22ppm/day and leveling below 25ppm/day.
    Fatalities are 6377ppm at 0.5ppm/day.
    FR is 6.0% from a 106608ppm detection recorded 7 days previously.
    Case FR short term is currently 3.0% .
    Peru test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 213% at 3100ppm/day
    - with 80% fully vaccinated

    Chile detections at 184594ppm (18.5%)
    Detection rate is 121ppm/day and falling.
    Fatalities are 2986ppm at 1.1ppm/day.
    FR is 1.6% from a 182800ppm detection recorded 14 days previously.
    Case FR short term is currently 0.6% .
    Chile test rate is 2280ppm/day.
    5.3% of current tests are positive.
    Vaccinations at 269% at 1700ppm/day.
    - with 91% fully vaccinated.

    Argentina detections at 198679ppm (19.9%)
    Detection rate is 0ppm/day and falling.
    Fatalities are 2814ppm at 0ppm/day.
    FR is 1.4% from a 198679ppm detection recorded 7 days previously.
    Case FR short term is currently 0% .
    Argentina test rate is 240ppm/day.
    0% of tests are positive.
    Vaccinations at 215% at 1500ppm/day
    - with 82% fully vaccinated.

    Mexico detections at 44017ppm (4.4%)
    Detection rate is 7ppm/day and leveling below 10ppm/day.
    Fatalities are 2488ppm at 0.2ppm/day.
    FR is 5.7% from a 43970ppm detection recorded 7 days previously.
    Case FR short term is currently 1.9% .
    Mexico test rate is 30ppm/day.
    No test positivity rate is practical.
    Vaccinations at 152% at 2700ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 62671ppm (6.3%)
    Detection rate is 52ppm/day and rising.
    Fatalities are 1671ppm at 0.4ppm/day.
    FR is 2.7% from a 62325ppm detection recorded 7 days previously.
    Case FR short term is currently 1.8%.
    SA test rate is 340ppm/day.
    15.3% of current tests are positive.
    Vaccinations at 58% at 600ppm/day
    - with 30% fully vaccinated.(a rounding error?)

    Czech detections at 363292ppm (36.3%)
    Detection rate is 183ppm/day and falling.
    Fatalities are 3738ppm at 1.2ppm/day.
    FR is 1.0% from a 362092ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5% .
    Czech test rate is 1270ppm/day.
    14.4% of current tests are positive.
    Vaccinations at 164% at 200ppm/day
    - with 64% fully vaccinated.

    India detections at 30903ppm (3.1%)
    Detection rate is 0ppm/day and leveling below 2ppm/day.
    Fatalities at 375ppm at 0.0ppm/day.
    FR is 1.2% from a 30892ppm detection recorded 7 days previously.
    Case FR short term is currently 3.7% .
    India test rate 290ppm/day.
    0.0% of current tests are positive.
    Vaccinations at 134% at 1200ppm/day
    - with 61% fully vaccinated.

    Israel detections at 436741ppm (43.7%)
    Detection rate is 400ppm/day and falling.
    Fatalities at 1148ppm at 0.6ppm/day.
    FR is 0.3% from a 434472ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 5410ppm/day.
    7.4% of current tests are positive
    Vaccinations at 195% at 100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Senegal - 9.5ppm/day
    Philipines - 8.7ppm/day
    Jamaica - 7.7ppm/day
    Malawi - 5.9ppm/day
    Surinam - 5.2ppm/day



    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate was double the long-term
    average of record until late April '22.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.

    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.

    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Mon May 2 18:17:27 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    It appears that covid infection fatality rates below 3ppm/day are
    to be considered as acceptible norms, post pandemic, for
    re-establishing unrestricted activity within political borders.

    As of May02:

    US detections are at 244395ppm.(24.4%)
    Detection rate is 161ppm/day and leveling below 190ppm/day.
    Fatalities are 2985ppm at 1.0ppm/day.
    FR is 1.2% from a 243260ppm detection recorded 7 days previously.
    Case FR short term is currently 0.8%.
    US test rate is 1680ppm/day.
    9.6% of current tests are positive.
    Vaccinations at 174% at 1100ppm/day
    - with 66% fully vaccinated.

    Canada detections at 98990ppm (9.9%) ~ 358 days behind the US.
    Detection rate at 195ppm/day and possibly leveling below 210ppm/day.
    Fatalities are 1033ppm at 1.7ppm/day. ~ 486 days behind the US.
    FR is 1.1% from a 97363ppm detection recorded 7 days previously.
    Case FR short term is currently 0.7%.
    Canada test rate is 1250ppm/day
    15.6% of current tests are positive.
    Vaccinations at 221% at 2400ppm/day
    - with 82% fully vaccinated.

    Italy detections at 273405ppm. (27.3%)
    Detection rate is 873ppm/day and falling.
    Fatalities are 2710ppm at 2.2ppm/day.
    FR is 1.1% from a 267297ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    Italy test rate is 5690ppm/day.
    15.3% of current tests are positive.
    Vaccinations at 227% at 500ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 246149ppm (24.6%)
    Detection rate is 36ppm/day and leveling below 40ppm/day.
    Fatalities are 1848ppm at 1.2ppm/day.
    FR is 0.7% from a 245900ppm detection recorded 7 days previously.
    Case FR short term is currently 2.1%.
    Sweden test rate is 310ppm/day.
    11.6% of current tests are positive.
    Vaccinations at 215% at 3100ppm/day
    - with 75% fully vaccinated.

    UK detections at 324199ppm. (32.4%)
    Detection rate is 222ppm/day and falling.
    Fatalities are 2567ppm at 3.3ppm/day.
    FR is 0.8% from a 322646ppm detection recorded 7 days previously.
    Case FR short term is currently 0.8%.
    UK test rate is 4710ppm/day.
    4.7% of current tests are positive.
    Vaccinations at 208% at 600ppm/day
    - with 73% fully vaccinated.

    Brazil detections at 142315ppm. (14.2%)
    Detection rate is 70ppm/day and leveling below 80ppm/day.
    Fatalities are 3101ppm at 0.6ppm/day
    FR is 2.2% from a 141824ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 201% at 2000ppm/day
    - with 77% fully vaccinated.

    Peru detections at 106892ppm. (10.7%)
    Detection rate is 21ppm/day and leveling below 25ppm/day.
    Fatalities are 6380ppm at 0.4ppm/day.
    FR is 6.0% from a 106743ppm detection recorded 7 days previously.
    Case FR short term is currently 2.2% .
    Peru test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 216% at 3800ppm/day
    - with 81% fully vaccinated

    Chile detections at 185350ppm (18.5%)
    Detection rate is 108ppm/day and falling.
    Fatalities are 2995ppm at 1.2ppm/day.
    FR is 1.6% from a 183815ppm detection recorded 14 days previously.
    Case FR short term is currently 1.0% .
    Chile test rate is 2190ppm/day.
    4.9% of current tests are positive.
    Vaccinations at 274% at 4300ppm/day.
    - with 91% fully vaccinated.

    Argentina detections at 199178ppm (19.9%)
    Detection rate is 71ppm/day and falling.
    Fatalities are 2881ppm at 1.0ppm/day.
    FR is 1.4% from a 198679ppm detection recorded 7 days previously.
    Case FR short term is currently 6.6% .
    Argentina test rate is 210ppm/day.
    33.8% of tests are positive.
    Vaccinations at 217% at 1700ppm/day
    - with 82% fully vaccinated.

    Mexico detections at 44063ppm (4.4%)
    Detection rate is 8ppm/day and leveling below 10ppm/day.
    Fatalities are 2490ppm at 0.2ppm/day.
    FR is 5.7% from a 44017ppm detection recorded 7 days previously.
    Case FR short term is currently 3.6% .
    Mexico test rate is 30ppm/day.
    No test positivity rate is practical.
    Vaccinations at 152% at 2900ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 63218ppm (6.3%)
    Detection rate is 78ppm/day and rising.
    Fatalities are 1672ppm at 0.1ppm/day.
    FR is 2.7% from a 62671ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4%.
    SA test rate is 380ppm/day.
    20.5% of current tests are positive.
    Vaccinations at 58% at 700ppm/day
    - with 31% fully vaccinated.(a rounding error?)

    Czech detections at 364220ppm (36.4%)
    Detection rate is 133ppm/day and falling.
    Fatalities are 3745ppm at 1.1ppm/day.
    FR is 1.0% from a 363292ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5% .
    Czech test rate is 1160ppm/day.
    11.5% of current tests are positive.
    Vaccinations at 169% at 200ppm/day
    - with 64% fully vaccinated.

    India detections at 30919ppm (3.1%)
    Detection rate is 2ppm/day and leveling below 3ppm/day.
    Fatalities at 376ppm at 0.2ppm/day.
    FR is 1.2% from a 30903ppm detection recorded 7 days previously.
    Case FR short term is currently 3.8% .
    India test rate 310ppm/day.
    0.6% of current tests are positive.
    Vaccinations at 136% at 1500ppm/day
    - with 62% fully vaccinated.

    Israel detections at 438904ppm (43.9%)
    Detection rate is 309ppm/day and falling.
    Fatalities at 1151ppm at 0.4ppm/day.
    FR is 0.3% from a 436741ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 5600ppm/day.
    5.5% of current tests are positive
    Vaccinations at 195% at <100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Finland - 7.8ppm/day


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate was double the long-term
    average of record until late April '22.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.

    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.

    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Tue May 10 14:14:38 2022
    On Wed, 06 Apr 2022 11:50:35 -0400, legg <legg@nospam.magma.ca> wrote:

    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated May 01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_032c.jpg

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Tue May 10 13:26:53 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    It appears that covid infection fatality rates below 3ppm/day are
    to be considered as acceptible norms, post pandemic, for
    re-establishing unrestricted activity within political borders.

    As of May09:

    US detections are at 246230ppm.(24.6%)
    Detection rate is 221ppm/day and rising.
    Fatalities are 2999ppm at 1.8ppm/day.
    FR is 1.2% from a 244395ppm detection recorded 7 days previously.
    Case FR short term is currently 1.1%.
    US test rate is 1990ppm/day.
    11.1% of current tests are positive.
    Vaccinations at 174% at 800ppm/day
    - with 66% fully vaccinated.

    Canada detections at 100091ppm (10.0%) ~ 363 days behind the US.
    Detection rate at 147ppm/day and possibly leveling below 180ppm/day.
    Fatalities are 1046ppm at 1.9ppm/day. ~ 484 days behind the US.
    FR is 1.1% from a 98990ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9%.
    Canada test rate is 1060ppm/day
    13.9% of current tests are positive.
    Vaccinations at 222% at 1500ppm/day
    - with 82% fully vaccinated.

    Italy detections at 278578ppm. (27.9%)
    Detection rate is 692ppm/day and falling.
    Fatalities are 2726ppm at 2.0ppm/day.
    FR is 1.0% from a 273405ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    Italy test rate is 4750ppm/day.
    14.6% of current tests are positive.
    Vaccinations at 227% at 600ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 246363ppm (24.6%)
    Detection rate is 31ppm/day and leveling below 40ppm/day.
    Fatalities are 1853ppm at 1.2ppm/day.
    FR is 0.8% from a 246149ppm detection recorded 7 days previously.
    Case FR short term is currently 2.2%.
    Sweden test rate is 310ppm/day.
    10.0% of current tests are positive.
    Vaccinations at unreported at 3300ppm/day
    - with 75% fully vaccinated.

    UK detections at 325701ppm. (32.6%)
    Detection rate is 215ppm/day and falling.
    Fatalities are 2589ppm at 3.2ppm/day.
    FR is 0.8% from a 324199ppm detection recorded 7 days previously.
    Case FR short term is currently 1.4%.
    UK test rate is 3820ppm/day.
    5.6% of current tests are positive.
    Vaccinations at 209% at 500ppm/day
    - with 73% fully vaccinated.

    Brazil detections at 142875ppm. (14.3%)
    Detection rate is 76ppm/day and leveling below 80ppm/day.
    Fatalities are 3105ppm at 0.4ppm/day
    FR is 2.2% from a 142315ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 202% at 1600ppm/day
    - with 77% fully vaccinated.

    Peru detections at 107010ppm. (10.7%)
    Detection rate is 20ppm/day and leveling below 25ppm/day.
    Fatalities are 6383ppm at 0.5ppm/day.
    FR is 6.0% from a 106892ppm detection recorded 7 days previously.
    Case FR short term is currently 2.0% .
    Peru test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 216% at 3700ppm/day
    - with 81% fully vaccinated

    Chile detections at 186410ppm (18.6%)
    Detection rate is 140ppm/day and rising.
    Fatalities are 3000ppm at 0.7ppm/day.
    FR is 1.6% from a 184594ppm detection recorded 14 days previously.
    Case FR short term is currently 0.7% .
    Chile test rate is 2310ppm/day.
    6.1% of current tests are positive.
    Vaccinations at 277% at 4500ppm/day.
    - with 91% fully vaccinated.

    Argentina detections at 199565ppm (20.0%)
    Detection rate is 36ppm/day and falling.
    Fatalities are 2823ppm? at 0.2ppm/day.
    FR is 1.4% from a 199178ppm detection recorded 7 days previously.
    Case FR short term is currently 0.7% .
    Argentina test rate is 230ppm/day.
    15.6% of tests are positive.
    Vaccinations at 218% at 200ppm/day
    - with 82% fully vaccinated.

    Mexico detections at 44108ppm (4.4%)
    Detection rate is 7ppm/day and leveling below 10ppm/day.
    Fatalities are 2491ppm at 0.1ppm/day.
    FR is 5.7% from a 44063ppm detection recorded 7 days previously.
    Case FR short term is currently 1.8% .
    Mexico test rate is 30ppm/day.
    No test positivity rate is practical.
    Vaccinations at 155% at 3600ppm/day.
    - with nr% fully vaccinated.

    South Africa detections at 64032ppm (6.4%)
    Detection rate is 110ppm/day and rising.
    Fatalities are 1674ppm at 0.4ppm/day.
    FR is 2.6% from a 63218ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5%.
    SA test rate is 430ppm/day.
    No test positivity rate is practical.
    Vaccinations at 59% at 600ppm/day
    - with 31% fully vaccinated.(a rounding error?)

    Czech detections at 364816ppm (36.5%)
    Detection rate is 97ppm/day and falling.
    Fatalities are 3750ppm at 0.6ppm/day.
    FR is 1.0% from a 364220ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Czech test rate is 890ppm/day.
    10.9% of current tests are positive.
    Vaccinations at 164% at 200ppm/day
    - with 64% fully vaccinated.

    India detections at 30937ppm (3.1%)
    Detection rate is 2ppm/day and leveling below 3ppm/day.
    Fatalities at 376ppm at 0.0ppm/day.
    FR is 1.2% from a 30919ppm detection recorded 7 days previously.
    Case FR short term is currently 1.0% .
    India test rate 280ppm/day.
    0.7% of current tests are positive.
    Vaccinations at 137% at 1100ppm/day
    - with 62% fully vaccinated.

    Israel detections at 440795ppm (44.1%)
    Detection rate is 230ppm/day and falling.
    Fatalities at 1156ppm at 0.1ppm/day.
    FR is 0.3% from a 438904ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2% .
    Israel test rate is 5120ppm/day.
    4.5% of current tests are positive
    Vaccinations at 195% at <100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Finland - 5.4ppm/day


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate was double the long-term
    average of record until late April '22.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.

    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.

    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Tue May 17 10:59:40 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    It appears that covid infection fatality rates below 3ppm/day are
    to be considered as acceptible norms, post pandemic, for
    re-establishing unrestricted activity within political borders.

    As of May16:

    US detections are at 247717ppm.(24.8%)
    Detection rate is 260ppm/day and rising.
    Fatalities are 3003ppm at 0.9ppm/day.
    FR is 1.2% from a 246230ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5%.
    US test rate is 2200ppm/day.
    11.8% of current tests are positive.
    Vaccinations at 175% at 800ppm/day
    - with 66% fully vaccinated.

    Canada detections at 100808ppm (10.1%) ~ 360 days behind the US.
    Detection rate at 111ppm/day and possibly leveling below 160ppm/day.
    Fatalities are 1058ppm at 1.7ppm/day. ~ 499 days behind the US.
    FR is 1.1% from a 100091ppm detection recorded 7 days previously.
    Case FR short term is currently 1.0%.
    Canada test rate is 1030ppm/day
    10.8% of current tests are positive.
    Vaccinations at 223% at 1200ppm/day
    - with 82% fully vaccinated.

    Italy detections at 282567ppm. (28.3%)
    Detection rate is 613ppm/day and falling.
    Fatalities are 2737ppm at 1.8ppm/day.
    FR is 1.0% from a 278578ppm detection recorded 7 days previously.
    Case FR short term is currently 0.2%.
    Italy test rate is 4220ppm/day.
    14.5% of current tests are positive.
    Vaccinations at 227% at 500ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 246541ppm (24.7%)
    Detection rate is 31ppm/day and leveling below 40ppm/day.
    Fatalities are 1860ppm at 0.7ppm/day.
    FR is 0.8% from a 246363ppm detection recorded 7 days previously.
    Case FR short term is currently 2.9%.
    Sweden test rate is 290ppm/day.
    10.6% of current tests are positive.
    Vaccinations at 219% at 2200ppm/day
    - with 75% fully vaccinated.

    UK detections at 326290ppm. (32.6%)
    Detection rate is 139ppm/day and falling.
    Fatalities are 2601ppm at 2.2ppm/day.
    FR is 0.8% from a 325701ppm detection recorded 7 days previously.
    Case FR short term is currently 1.3%.
    UK test rate is 3560ppm/day.
    3.9% of current tests are positive.
    Vaccinations are not reported
    - with ~73% fully vaccinated.

    Brazil detections at 143408ppm. (14.3%)
    Detection rate is 83ppm/day and leveling below 90ppm/day.
    Fatalities are 3108ppm at 0.5ppm/day
    FR is 2.2% from a 142875ppm detection recorded 7 days previously.
    Case FR short term is currently 0.7% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 203% at 2100ppm/day
    - with 77% fully vaccinated.

    Peru detections at 107062ppm. (10.7%)
    Detection rate is 11ppm/day and leveling below 25ppm/day.
    Fatalities are 6385ppm at 0.4ppm/day.
    FR is 6.0% from a 107010ppm detection recorded 7 days previously.
    Case FR short term is currently 1.9% .
    Peru test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 220% at 2000ppm/day
    - with 81% fully vaccinated

    Chile detections at 187667ppm (18.8%)
    Detection rate is 219ppm/day and rising.
    Fatalities are 3004ppm at 0.7ppm/day.
    FR is 1.6% from a 185330ppm detection recorded 14 days previously.
    Case FR short term is currently 0.6% .
    Chile test rate is 2460ppm/day.
    8.9% of current tests are positive.
    Vaccinations at 282% at 5600ppm/day.
    - with 91% fully vaccinated.

    Argentina detections at 200310ppm (20.0%)
    Detection rate is 106ppm/day and rising.
    Fatalities are 2824ppm? at 0.2ppm/day.
    FR is 1.4% from a 199565ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Argentina test rate is 330ppm/day.
    32% of tests are positive.
    Vaccinations at 220% at 2600ppm/day
    - with 82% fully vaccinated.

    Mexico detections at 44108ppm (4.4%)
    Detection rate is 7ppm/day and leveling below 10ppm/day.
    Fatalities are 2491ppm at 0.1ppm/day.
    FR is 5.7% from a 44108ppm detection recorded 7 days previously.
    Case FR short term is currently 1.8% .
    Mexico test rate is 30ppm/day.
    No test positivity rate is practical.
    Vaccinations are unreported.
    - with nr% fully vaccinated.

    South Africa detections at 64813ppm (6.5%)
    Detection rate is 120ppm/day and rising.
    Fatalities are 1678ppm at 0.6ppm/day.
    FR is 2.6% from a 64032ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6%.
    SA test rate is 470ppm/day.
    26% of tests are positive.
    Vaccinations at 59% at 700ppm/day
    - with 31% fully vaccinated.(a rounding error?)

    Czech detections at 365136ppm (36.5%)
    Detection rate is 46ppm/day and falling.
    Fatalities are 3753ppm at 0.4ppm/day.
    FR is 1.0% from a 364816ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3% .
    Czech test rate is 630ppm/day.
    17.3% of current tests are positive.
    Vaccinations at 164% at 200ppm/day
    - with 64% fully vaccinated.

    India detections at 30948ppm (3.1%)
    Detection rate is 2ppm/day and leveling below 3ppm/day.
    Fatalities at 376ppm at 0.0ppm/day.
    FR is 1.2% from a 30937ppm detection recorded 7 days previously.
    Case FR short term is currently 0.7% .
    India test rate 320ppm/day.
    0.6% of current tests are positive.
    Vaccinations at 137% at 1100ppm/day
    - with 63% fully vaccinated.

    Israel detections at 442191ppm (44.2%)
    Detection rate is 251ppm/day and leveling below 300ppm/day.
    Fatalities at 1162ppm at 0.9ppm/day.
    FR is 0.3% from a 440795ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4% .
    Israel test rate is 5410ppm/day.
    4.6% of current tests are positive
    Vaccinations at 195% at <100ppm/day.
    - with 66% fully vaccinated.

    There are no fatality rate hotspots (>5ppm/day) :


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate was double the long-term
    average of record until late April '22.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.

    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.

    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Tue May 24 02:14:25 2022
    Per capita comparisons are interesting, as they represent
    efforts, within political boundaries, equally.
    Data is easily obtained by visiting the data explorer page
    at Our World in Data:

    http://tiny.cc/ul41tz


    A 100ppm daily detection rate would, in one year, result in
    an approximately 4% penetration within a population.

    Testing of blood donor samples in Quebec suggests that covid-19
    antibodies are present in the local population at 3x positive
    virus detection test rate, in early 2020.

    Testing for antibodies in India in May/Jun 2021, indicated that
    Covid 19 exposure was present in 67% of test subjects. This
    compared to a 7% figure recorded in the fall of 2020. A daily
    infection rate in excess of 2000ppm is suggested by this change.

    http://tiny.cc/cn8muz


    multiply ppm by population (in millions) for real numbers.
    China - 1397 million
    Iceland - 0.36 million
    US - 330 million
    Canada - 37 million
    Italy - 60 million
    Sweden - 10 million
    UK - 66 million
    Brazil - 210 million
    Peru - 32 million
    Chile - 19 million
    Argentina - 45 million
    Mexico - 127 million
    South Africa - 58 million
    Czech Republic - 10.7 million
    Israel - 10 million
    India - 1391 million

    Median age in Germany and Italy is 45-46yrs.
    Median age in Canada, UK and Sweden is 40-41yrs.
    Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively. Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
    Median age in Israel is 30.4yrs.
    Median age in Peru and Mexico is 27.5yrs.
    Median age in India is 26.8yrs.
    Median age in South Africa is 25yrs.


    Comparison charts, as of Mar01 are available:


    http://ve3ute.ca/query/220404_cases_ppm_report_group.jpg http://ve3ute.ca/query/220404_cases_daily_ppm_report_group.jpg

    http://ve3ute.ca/query/220404_deaths_report_group.jpg http://ve3ute.ca/query/220404_deaths_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_ppm_report_group.jpg http://ve3ute.ca/query/220404_deaths_daily_worl_map.jpg

    http://ve3ute.ca/query/220404_vaccine_doses_report_group.jpg http://ve3ute.ca/query/220404_vaccine_doses_daily_report_group.jpg http://ve3ute.ca/query/220404_vaccinations_completed_report_group.jpg


    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Mar01 to include a second year trend or 'season'.

    http://ve3ute.ca/query/flu_season_029c.jpg

    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    It appears that covid infection fatality rates below 3ppm/day are
    to be considered as acceptible norms, post pandemic, for
    re-establishing unrestricted activity within political borders.

    As of May23:

    US detections are at 250103ppm.(25.0%)
    Detection rate is 347ppm/day and rising.
    Fatalities are 3010ppm at 1.1ppm/day.
    FR is 1.2% from a 247717ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4%.
    US test rate is 2290ppm/day.
    15.2% of current tests are positive.
    Vaccinations at 176% at 800ppm/day
    - with 67% fully vaccinated.

    Canada detections at 101465ppm (10.1%) ~ 353 days behind the US.
    Detection rate at 96ppm/day and possibly leveling below 130ppm/day.
    Fatalities are 1070ppm at 1.7ppm/day. ~ 503 days behind the US.
    FR is 1.1% from a 100808ppm detection recorded 7 days previously.
    Case FR short term is currently 1.3%.
    Canada test rate is 910ppm/day
    10.5% of current tests are positive.
    Vaccinations at 223% at 1200ppm/day
    - with 82% fully vaccinated.

    Italy detections at 285406ppm. (28.5%)
    Detection rate is 471ppm/day and falling.
    Fatalities are 2748ppm at 1.7ppm/day.
    FR is 1.0% from a 282567ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3%.
    Italy test rate is 3810ppm/day.
    12.45% of current tests are positive.
    Vaccinations at 228% at 500ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 246709ppm (24.7%)
    Detection rate is 24ppm/day and leveling below 40ppm/day.
    Fatalities are 1864ppm at 0.6ppm/day.
    FR is 0.8% from a 246541ppm detection recorded 7 days previously.
    Case FR short term is currently 3.4%.
    Sweden test rate is 290ppm/day.
    8.3% of current tests are positive.
    Vaccinations at 220% at 1800ppm/day
    - with 75% fully vaccinated.

    UK detections at 327158ppm. (32.7%)
    Detection rate is 124ppm/day and falling.
    Fatalities are 2612ppm at 1.5ppm/day.
    FR is 0.8% from a 326290ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9%.
    UK test rate is 3390ppm/day.
    3.7% of current tests are positive.
    Vaccinations are not reported
    - with ~73% fully vaccinated.

    Brazil detections at 143754ppm. (14.4%)
    Detection rate is 54ppm/day and leveling below 70ppm/day.
    Fatalities are 3111ppm at 0.2ppm/day
    FR is 2.2% from a 143408ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 204% at 1300ppm/day
    - with 77% fully vaccinated.

    Peru detections at 107175ppm. (10.7%)
    Detection rate is 23ppm/day and leveling below 25ppm/day.
    Fatalities are 6388ppm at 0.4ppm/day.
    FR is 6.0% from a 107062ppm detection recorded 7 days previously.
    Case FR short term is currently 3.4% .
    Peru test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 220% at 2000ppm/day
    - with 81% fully vaccinated

    Chile detections at 189305ppm (18.9%)
    Detection rate is 268ppm/day and rising.
    Fatalities are 3008ppm at 0.6ppm/day.
    FR is 1.6% from a 186410ppm detection recorded 14 days previously.
    Case FR short term is currently 0.4% .
    Chile test rate is 2840ppm/day.
    9.4% of current tests are positive.
    Vaccinations at 286% at 7100ppm/day.
    - with 91% fully vaccinated.

    Argentina detections at 200310ppm (20.0%)
    Detection rate is 106ppm/day and rising.
    Fatalities are 2824ppm? at 0.2ppm/day.
    FR is 1.4% from a 200310ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3% .
    Argentina test rate is 340ppm/day.
    31% of tests are positive.
    Vaccinations at 222% at 1900ppm/day
    - with 82% fully vaccinated.

    Mexico detections at 44160ppm (4.4%)
    Detection rate is 8ppm/day and leveling below 10ppm/day.
    Fatalities are 2492ppm at 0.2ppm/day.
    FR is 5.7% from a 44108ppm detection recorded 7 days previously.
    Case FR short term is currently 3.7% .
    Mexico test rate is 40ppm/day.
    No test positivity rate is practical.
    Vaccinations at 159% at 3800ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 65398ppm (6.5%)
    Detection rate is 93ppm/day and possibly leveling below 100ppm/day.
    Fatalities are 1681ppm at 0.4ppm/day.
    FR is 2.6% from a 64813ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3%.
    SA test rate is 440ppm/day.
    21% of tests are positive.
    Vaccinations at 60% at 700ppm/day
    - with 31% fully vaccinated.(a rounding error?)

    Czech detections at 365336ppm (36.5%)
    Detection rate is 30ppm/day and falling.
    Fatalities are 3755ppm at 0.3ppm/day.
    FR is 1.0% from a 365136ppm detection recorded 7 days previously.
    Case FR short term is currently 0.6% .
    Czech test rate is 530ppm/day.
    5.7% of current tests are positive.
    Vaccinations at 164% at 200ppm/day
    - with 64% fully vaccinated.

    India detections at 30957ppm (3.1%)
    Detection rate is 2ppm/day and leveling below 3ppm/day.
    Fatalities at 376ppm at 0.0ppm/day.
    FR is 1.2% from a 30948ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9% .
    India test rate 360ppm/day.
    0.6% of current tests are positive.
    Vaccinations at 138% at 1000ppm/day
    - with 63% fully vaccinated.

    Israel detections at 443506ppm (44.4%)
    Detection rate is 235ppm/day and leveling below 260ppm/day.
    Fatalities at 1165ppm at 1.2ppm/day.
    FR is 0.3% from a 442191ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5% .
    Israel test rate is 4910ppm/day.
    4.8% of current tests are positive
    Vaccinations at 195% at <100ppm/day.
    - with 66% fully vaccinated.

    Fatality rate hotspots (>5ppm/day) :

    Iceland 12.8ppm/day (book keeping?)


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate was double the long-term
    average of record until late April '22.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.

    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.

    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Mon May 30 17:49:04 2022
    Looks like everyone's going to get it, eventually, vaccinated
    or not - just reduced mortality amongst the vaccinated.

    Past sero-immunity studies suggest that a 30% detection record
    could indicate widespread (>80%) penetration in a population.

    It appears that covid infection fatality rates below 3ppm/day are
    to be considered as acceptible norms, post pandemic, for
    re-establishing unrestricted activity within political borders.

    - So, as of this date, these summaries will cease, with
    fingers crossed.

    As of May30:

    US detections are at 252258ppm.(25.2%)
    Detection rate is 307ppm/day and possibly leveling below 330ppm/day.
    Fatalities are 3018ppm at 1.1ppm/day.
    FR is 1.2% from a 250103ppm detection recorded 7 days previously.
    Case FR short term is currently 0.4%.
    US test rate is 2200ppm/day.
    14.0% of current tests are positive.
    Vaccinations at 177% at 1000ppm/day
    - with 67% fully vaccinated.

    Canada detections at 101945ppm (10.2%) ~ 381 days behind the US.
    Detection rate at 69ppm/day and possibly leveling below 100ppm/day.
    Fatalities are 1078ppm at 1.2ppm/day. ~ 511 days behind the US.
    FR is 1.1% from a 101465ppm detection recorded 7 days previously.
    Case FR short term is currently 1.1%.
    Canada test rate is 690ppm/day
    10.0% of current tests are positive.
    Vaccinations at 224% at 1000ppm/day
    - with 82% fully vaccinated.

    Italy detections at 287800ppm. (28.8%)
    Detection rate is 342ppm/day and falling.
    Fatalities are 2759ppm at 1.5ppm/day.
    FR is 1.0% from a 285406ppm detection recorded 7 days previously.
    Case FR short term is currently 0.3%.
    Italy test rate is 3250ppm/day.
    10.5% of current tests are positive.
    Vaccinations at 228% at 400ppm/day.
    - with 79% fully vaccinated.

    Sweden detections at 246841ppm (24.7%)
    Detection rate is 24ppm/day and leveling below 40ppm/day.
    Fatalities are 1868ppm at 1.1ppm/day.
    FR is 0.8% from a 246709ppm detection recorded 7 days previously.
    Case FR short term is currently 4.1%.
    Sweden test rate is 260ppm/day.
    9.2% of current tests are positive.
    Vaccinations at 220% at 1800ppm/day
    - with 75% fully vaccinated.

    UK detections at 327735ppm. (32.8%)
    Detection rate is 91ppm/day and falling.
    Fatalities are 2619ppm at 1.2ppm/day.
    FR is 0.8% from a 327158ppm detection recorded 7 days previously.
    Case FR short term is currently 0.8%.
    UK test rate is unreported (~3390ppm/day).
    ~2.7% of current tests are positive.
    Vaccinations at 209% at 500ppm/day.
    - with ~73% fully vaccinated.

    Brazil detections at 144609ppm. (14.5%)
    Detection rate is 122ppm/day and rising.
    Fatalities are 3114ppm at 0.5ppm/day
    FR is 2.2% from a 143754ppm detection recorded 7 days previously.
    Case FR short term is currently 0.9% .
    Brazil test rate is not reported.
    No test positivity rate is practical.
    Vaccinations at 206% at 2100ppm/day
    - with 78% fully vaccinated.

    Peru detections at 107302ppm. (10.7%)
    Detection rate is 18ppm/day and leveling below 25ppm/day.
    Fatalities are 6390ppm at 0.3ppm/day.
    FR is 6.0% from a 107175ppm detection recorded 7 days previously.
    Case FR short term is currently 1.2% .
    Peru test rate is unreported.
    No test positivity rate is practical.
    Vaccinations at 225% at 2600ppm/day
    - with 82% fully vaccinated.

    Chile detections at 191782ppm (19.2%)
    Detection rate is 354ppm/day and rising.
    Fatalities are 3012ppm at 0.6ppm/day.
    FR is 1.6% from a 187667ppm detection recorded 14 days previously.
    Case FR short term is currently 0.3% .
    Chile test rate is 3010ppm/day.
    11.8% of current tests are positive.
    Vaccinations at 292% at 6700ppm/day.
    - with 91% fully vaccinated.

    Argentina detections at 201864ppm (20.2%)
    Detection rate is 136ppm/day and rising.
    Fatalities are 2825ppm? at 0.2ppm/day.
    FR is 1.4% from a 200310ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Argentina test rate is 390ppm/day.
    34.9% of tests are positive.
    Vaccinations at 225% at 3000ppm/day
    - with 82% fully vaccinated.

    Mexico detections at 44217ppm (4.4%)
    Detection rate is 7ppm/day and leveling below 10ppm/day.
    Fatalities are 2493ppm at 0.2ppm/day.
    FR is 5.7% from a 44160ppm detection recorded 7 days previously.
    Case FR short term is currently 2.5% .
    Mexico test rate is 40ppm/day.
    No test positivity rate is practical.
    Vaccinations at 159% at 1400ppm/day.
    - with 61% fully vaccinated.

    South Africa detections at 65824ppm (6.6%)
    Detection rate is 61ppm/day and falling.
    Fatalities are 1685ppm at 0.5ppm/day.
    FR is 2.6% from a 65398ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5%.
    SA test rate is 700ppm/day.
    8.7% of tests are positive.
    Vaccinations at 60% at 700ppm/day
    - with 31% fully vaccinated.(a rounding error?)

    Czech detections at 365479ppm (36.5%)
    Detection rate is 20ppm/day and falling.
    Fatalities are 3756ppm at 0.2ppm/day.
    FR is 1.0% from a 365336ppm detection recorded 7 days previously.
    Case FR short term is currently 0.5% .
    Czech test rate is 480ppm/day.
    4.2% of current tests are positive.
    Vaccinations at 164% at 200ppm/day
    - with 64% fully vaccinated.

    India detections at 30969ppm (3.1%)
    Detection rate is 2ppm/day and leveling below 3ppm/day.
    Fatalities at 376ppm at 0.0ppm/day.
    FR is 1.2% from a 30957ppm detection recorded 7 days previously.
    Case FR short term is currently 1.1% .
    India test rate 300ppm/day.
    0.7% of current tests are positive.
    Vaccinations at 138% at 1000ppm/day
    - with 64% fully vaccinated.

    Israel detections at 444915ppm (44.5%)
    Detection rate is 201ppm/day and falling.
    Fatalities at 1167ppm at 0.2ppm/day.
    FR is 0.3% from a 443506ppm detection recorded 7 days previously.
    Case FR short term is currently 0.1% .
    Israel test rate is 2160ppm/day.
    9.3% of current tests are positive
    Vaccinations at 195% at <100ppm/day.
    - with 66% fully vaccinated.

    No fatality rate hotspots (>5ppm/day) are reported.


    Pfizer is recommending a 4th vaccine dose to maintain reduced
    mortality rates, based on their Israeli trials. There is no news
    w/r to omicron-specific vaccine tests. Israeli vaccination rates
    have stalled at 66% for half a year, suggesting that this may be
    part of their testing protocol.

    Although omicron is considered less fatal than earlier variants,
    the US short-term fatality rate was double the long-term
    average of record until late April '22.

    As detection levels rise above 15% of the total population ( >30%
    in some cases), and assymptomatic infection levels at >3:1, it
    may become safe to assume that very large levels of a population
    have 'had' covid19 and that present infections are caused by
    variants that are not suppressed by current vaccination efforts.
    Without an accompanying mortality, these new variants are
    unconvincing candidates for further vaccination development.

    Doses applied in Israel, Chile and other highly vaccinated countries
    appear to be providing 3rd dose booster reinforcement, without
    contributing to completed vaccinations.

    Full vaccination levels are apparently stalled around 60% in the US
    and other regions with signifigant reactionary movements.

    The increased transmissibility of omicron variants have contributed
    to the rise in detections, world-wide, after Nov 2021. So far, no
    increase in mortality is associated with this variant.

    Chile participated in Phase 3 trials for AstraZeneca,
    Johnson & Johnson, Sinovac and CanSino. Chile has contracts
    with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
    Sinovac is their regular supplier of seasonal flu vaccine.
    Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
    temperatures. About 60% of Chile's contracted 80 million doses
    are from Sinovac.

    Chile maintains a Public Health service database that includes
    regular vaccination scheduling. Using these resources alone
    allowed vaccination rates as high as 1 million doses per week
    to be delivered as early as mid-February. Approval of vaccine
    use was based on published Phase 1 and Phase 2 reporting.


    Reducing detections and fatalities in unvaccinated India/Nepal
    seem to indicate reducing virulence for the delta variant.
    Detection rates in S.Africa had also turned around until the
    recent influences of the omicron variant. So far there is no
    corresponding increase in fatalities.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Thu Jun 9 11:03:36 2022
    On Wed, 06 Apr 2022 11:50:35 -0400, legg <legg@nospam.magma.ca> wrote:

    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Jun01 to include a third year trend or 'season'.

    http://ve3ute.ca/query/flu_season_034c.jpg

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Thu Jul 7 23:34:56 2022
    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated July01 to include a third year trend or 'season'.

    http://ve3ute.ca/query/flu_season_035c.jpg

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Mon Aug 1 17:46:48 2022
    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Aug01 to include a third year trend or 'season'.

    http://ve3ute.ca/query/flu_season_036c.jpg

    Looks like the hopes of a fatality curve similar to the
    2017-18 or 2015-15 flu seasons are fading, as vaccination,
    masking and distancing precautions are dropped.

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From legg@21:1/5 to All on Thu Sep 1 09:47:16 2022
    Flu Season? Fatality comparison to past events in the U.S.A.
    Updated Jun01 to include a third year trend or 'season'.

    http://ve3ute.ca/query/flu_season_036c.jpg

    RL

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)